nach oben

Annals of Surgical Oncology

Erschienen in:

01.05.2007 | Educational Review

Magnetic Resonance–Guided Focused Ultrasound Surgery for the Noninvasive Curative Ablation of Tumors and Palliative Treatments: A Review

verfasst von: Doron Kopelman, MD, Moshe Papa, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Abstract

This article reviews and discusses the up-to-date data on and feasibility of focused ultrasound surgery. This technique uses high-energy ultrasound beams that can be directed to penetrate through the skin and various soft tissues, focus on the target, and destroy tumors by increasing the temperature at the targeted tissue volume. The boundaries of the treatment area are sharply demarcated (focused) without causing damage to the surrounding organs. Although the idea of using sound waves to ablate tumors was first demonstrated in the 1940 s, only recent developments have enabled this technology to become more controlled and, hence, more feasible. The major breakthrough toward its clinical use came with coupling the thermal ablative process to advanced imaging. The development of magnetic resonance as the foundation to guide and evaluate the end results of focused ultrasound surgery treatment, the image guidance of the ultrasound beam, and the development of a reliable method for tissue temperature measurement and real-time feedback of the extent of tissue destruction have pushed this novel technology forward in oncological practice.

Wood R, Loomis A. The physical and biological effects of high frequency sound waves of greater intensity. London Edinburgh Dublin Philos Mag J Sci 1927; 4:417–36

Gruetzmacher J. Piezoelektrischer kristall mit ultraschallkonvergenz. Z Phys 1935; 96:342–9CrossRef

Lynn J, Zwemer R, Chick A, Miller A. A new method for the generation and use of focused ultrasound in experimental biology. J Gen Physiol 1942; 26:179–93CrossRef

Fry W, Barnard J, Fry F, Krumins R, Brennan J. Ultrasonic lesions in the mammalian central nervous system. Science 1942; 122:517–8CrossRef

Wall P, Fry W, Stephens R. Changes produced in the central nervous system by ultrasound. Science 1951; 114:686–7PubMedCrossRef

Fry WJ, Mosberg WH, Barnard JW, Fry FJ. Production of focal destructive lesions in the central nervous system with ultrasound. J Neurosurg 1954; 11:471–8PubMed

Fry FJ. Precision high intensity focusing ultrasonic machines for surgery. Am J Phys Med 1958; 37:152–6PubMed

Meyers R, Fry W, Fry F. Early experiences with ultrasonic irradiation of the pallidofugal and nigral complexes in hyperkinetic and hypertonic disorders. J Neurosurg 1959; 16:32–54PubMed

Szent Gyorgyi A. Chemical and biological effects of ultrasonic radiation. Nature 1933; 131:278

10.

Burov A, Andreevskaya G. The effect of ultra-acoustic oscillation of high intensity on malignant tumors in animals and man. Dokl Akad Nauk SSSR 1956; 106:445–8

11.

Oka M. Progress in studies of the potential use of medical ultrasonics. Wakayama Med Rep (Japan) 1977; 20:1–50

12.

Fry WJ, Fry FJ. Fundamental neurological research and human neurosurgery using intense ultrasound. IRE Trans Med Electron 1960; 7:166-81PubMedCrossRef

13.

Kishi M, Mishima T, Itakura T, Tsuda K, Oka M. Experimental studies of effects of intense ultrasound on implantable murine glioma. In: Kazner E, de Vliger M, Muller HR, McCready VR, eds. Ultrasonics in medicine. Amsterdam: Excerpta Medica, 1975:28–33

14.

Fry F, Johnson L. Tumor irradiation with intense ultrasound. Ultrasound Med Biol 1978; 4:337–41PubMedCrossRef

15.

Linke C, Carstensen E, Frizzell L, Elbadawi A, Fridd C. Localized tissue destruction by high-intensity focused ultrasound. Arch Surg 1973; 107:887–91PubMed

16.

Fry F, Kossoff G, Eggleton R, Dunn F. Threshold ultrasound dosages for structural changes in the mammalian brain. J Acoust Soc Am 1970; 48:1413–7PubMedCrossRef

17.

Johnston RL, Dunn F. Ultrasonic absorbed dose, dose rate and produced lesion volume. Ultrasonics 1976; 14:153–5PubMedCrossRef

18.

Frizzell LA, Linke CA, Carstensen EL, Fridd CW. Thresholds for focal ultrasonic lesions in rabbit kidney, liver, and testicle. IEEE Trans Biomed Eng 1977; 24:393–6PubMedCrossRef

19.

Lele P. Production of deep focal lesions by focused ultrasound—current status. Ultrasonics 1967; 5:105–22PubMedCrossRef

20.

Lele P. A simple method for production of trackless focal lesions with focused ultrasound: physical factors. J Physiol 1962; 160:494–512PubMed

21.

Fry FJ, Ades HW, Fry WJ. Production of reversible changes in the central nervous system by ultrasound. Science 1958; 127:83-4PubMedCrossRef

22.

Lele PP. Fundamental and applied aspects of nonionizing radiation. In: Ultrasound in Surgery. New York: Plenum Press, 1975:325–40

23.

Silverman R, Vogelsang B, Rondeau M, Coleman D. Therapeutic ultrasound for the treatment of glaucoma. Am J Ophthalmol 1991; 111:327–37PubMed

24.

Rosecan L, Iwamoto T, Rosado A, Lizzi F, Coleman D. Therapeutic ultrasound in the treatment of retinal detachment: clinical observation and light and electron microscopy. Retina 1985; 5:115–22PubMedCrossRef

25.

Coleman DJ, Lizzi FL, Torpey JH, et al. Treatment of experimental lens capsular tears with intense focused ultrasound. Br J Ophthalmol 1985; 69:645–9PubMed

26.

Hynynen K, DeYoung D. Temperature elevation at muscle-bone interface during scanned, focused ultrasound hyperthermia. Int J Hyperthermia 1988; 4:267–79PubMed

27.

Hynynen K, Roemer R, Anhalt D, et al. A scanned, focused, multiple transducer ultrasonic system for localized hyperthermia treatments. Int J Hyperthermia 1987; 3:21–35PubMedCrossRef

28.

ter Haar G, Sinnett D, Rivens I. High intensity focused ultrasound—a surgical technique for the treatment of discrete liver tumours. Phys Med Biol 1989; 34:1743–50PubMedCrossRef

29.

Yang R, Reilly CR, Rescorla FJ, et al. High-intensity focused ultrasound in the treatment of experimental liver cancer. Arch Surg 1991; 126:1002–9; discussion 1009–10PubMed

30.

Yang R, Reilly CR, Rescorla FJ, et al. Effects of high intensity focused ultrasound in the treatment of experimental neuroblastoma. J Pediatr Surg 1992; 27:246–250; discussion 250–41PubMedCrossRef

31.

Sibille A, Prat F, Chapelon JY, et al. Extracorporeal ablation of liver tissue by high-intensity focused ultrasound. Oncology 1993; 50:375–9PubMedCrossRef

32.

Prat F, Centarti M, Sibille A, et al. Extracorporeal high intensity focused ultrasound for VX2 liver tumors in the rabbit. Hepatology 1995; 21:832–6PubMed

33.

Gelet A, Chapelon JY, Margonari J, et al. Prostatic tissue destruction by high-intensity focused ultrasound: experimentation on canine prostate. J Endourol 1993; 7:249–53PubMed

34.

Adams JB, Moore RG, Anderson JH, Strandberg JD, Marshall FF, Davoussi LR. High-intensity focused ultrasound ablation of rabbit kidney tumors. J Endourol 1996; 10:71–5PubMed

35.

Kincaide LF, Sanghvi NT, Cummings O, et al. Noninvasive ultrasonic subtotal ablation of the prostate in dogs. Am J Vet Res 1996; 57:1225–7PubMed

36.

Rowland IJ, Rivens I, Chen L, et al. MRI study of hepatic tumours following high intensity focused ultrasound surgery. Br J Radiol 1997; 70:144–53PubMed

37.

Watkin NA, Morris SB, Rivens IH, ter Haar GR. High intensity focused ultrasound ablation of the kidney in a large animal model. J Endourol 1997; 11:191–6PubMed

38.

Vallancien G, Chartier-Kastler E, Harouni M, Chopin D, Bougaran J. Focused extracorporeal pyrotherapy: experimental study and feasibility in man. Semin Urol 1993; 11:7–9PubMed

39.

Sandilos P, Tsalafoutas I, Koutsokalis G, et al. Radiation doses to patients from extracorporeal shock wave lithotripsy. Health Phys 2006; 90:583–7PubMedCrossRef

40.

Wu F, Chen WZ, Bai J, et al. Tumor vessel destruction resulting from high-intensity focused ultrasound in patients with solid malignancies. Ultrasound Med Biol 2002; 28:535–42PubMedCrossRef

41.

Mulligan ED, Lynch TH, Mulvin D, Greene D, Smith JM, Fitzpatrick JM. High-intensity focused ultrasound in the treatment of benign prostatic hyperplasia. Br J Urol 1997; 79:177–80PubMed

42.

Nakamura K, Baba S, Saito S, Tachibana M, Murai M. High-intensity focused ultrasound energy for benign prostatic hyperplasia: clinical response at 6 months to treatment using Sonablate 200. J Endourol 1997; 11:197–201PubMed

43.

Sullivan LD, McLoughlin MG, Goldenberg LG, Gleave ME, Marich KW. Early experience with high-intensity focused ultrasound for the treatment of benign prostatic hypertrophy. Br J Urol 1997; 79:172–6PubMed

44.

Uchida T, Sanghvi NT, Gardner TA, et al. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2N0M0 localized prostate cancer: a preliminary report. Urology 2002; 59:394–8; discussion 398–9PubMedCrossRef

45.

Gelet A, Chapelon JY, Bouvier R, et al. Transrectal high intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. J Endourol 2000; 14:519–28PubMed

46.

Sanghvi NT, Foster RS, Bihrle R, et al. Noninvasive surgery of prostate tissue by high intensity focused ultrasound: an updated report. Eur J Ultrasound 1999; 9:19–29PubMedCrossRef

47.

Chen L, ter Haar GR, Robertson D, Bensted JP, Hill CR. Histological study of normal and tumor-bearing liver treated with focused ultrasound. Ultrasound Med Biol 1999; 25:847–56PubMedCrossRef

48.

Visioly AG, Rivens IH, ter Haar GR, et al. Preliminary results of a phase I dose escalation clinical trial using focused ultrasound in the treatment of localized tumours. Eur J Ultrasound 1999; 9:11–8CrossRef

49.

Wu F, Chen WZ, Bai J, et al. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol 2001; 27:1099–06PubMedCrossRef

50.

Wu F, Wang Z-B, Chen W-Z, et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinoma. Ann Surg Oncol 2004; 11:1061–9PubMedCrossRef

51.

Li CX, Xu GL, Li JJ, Luo GY. High intensity focused ultrasound for liver cancer (in Chinese). Zhonghua Zhong Liu Za Zhi 2003; 25:94–6PubMed

52.

Chen W, Wang Z, Wu F, et al. High intensity focused ultrasound in the treatment of primary malignant bone tumor (in Chinese). Zhonghua Zhong Liu Za Zhi 2002; 24:612–5PubMed

53.

Chen W, Wang Z, Wu F, et al. High intensity focused ultrasound alone for malignant solid tumors (in Chinese). Zhonghua Zhong Liu Za Zhi 2002; 24:278–81PubMed

54.

Wang X, Sun J. High-intensity focused ultrasound in patients with late-stage pancreatic carcinoma. Chin Med J (Engl) 2002; 115:1332–5

55.

Paterson RF, Barret E, Siqueira TM Jr, et al. Laparoscopic partial kidney ablation with high intensity focused ultrasound. J Urol 2003; 169:347–51PubMedCrossRef

56.

Kohrmann KU, Michel MS, Gaa J, Marlinghaus E, Alken P. High intensity focused ultrasound as noninvasive therapy for multilocal renal cell carcinoma: case study and review of the literature. J Urol 2002; 167:2397–403PubMedCrossRef

57.

Hynynen K, Damianou C, Darkazanli A, Unger E, Schenck JF. The feasibility of using MRI to monitor and guide noninvasive ultrasound surgery. Ultrasound Med Biol 1993; 19:91–2PubMedCrossRef

58.

Cline HE, Hynynen K, Watkins RD, et al. Focused US system for MR imaging-guided tumor ablation. Radiology 1995; 194:731–7PubMed

59.

Hynynen K, Chung A, Fjield T, et al. Feasibility of using ultrasound phase arrays for MRI monitored noninvasive surgery. IEEE Trans Ultrasonics Ferroelectrics Frequency Control 1996; 43:1043–54CrossRef

60.

Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984; 10:787–800PubMed

61.

Jolesz FA, Bleier AR, Jakab P, Ruenzel PW, Huttl K, Jako GJ. MR imaging of laser-tissue interactions. Radiology 1988; 168:249–53PubMed

62.

McDannold NJ, King RL, Jolesz FA, Hynynen KH. Usefulness of MR imaging-derived thermometry and dosimetry in determining the threshold for tissue damage induced by thermal surgery in rabbits. Radiology 2000; 216:517–23PubMed

63.

Hazle JD, Stafford RJ, Price RE. Magnetic resonance imaging-guided focused ultrasound thermal therapy in experimental animal models: correlation of ablation volumes with pathology in rabbit muscle and VX2 tumors. J Magn Reson Imaging 2002; 15:185–94PubMedCrossRef

64.

Sokka SD, King R, Hynynen K. MRI-guided gas bubble enhanced ultrasound heating in vivo rabbit thigh. Phys Med Biol 2003; 48:223–41PubMedCrossRef

65.

Hynynen K. Focused ultrasound surgery guided by MRI. Sci Med 1996; 3(5). http://www.advanced-surgical.com/Documents/Science_and_Medicine/index.htm

66.

Kopelman D, Inbar Y, Hanannel A, et al. Magnetic resonance guided focused ultrasound surgery (MRgFUS), accelerated non-invasive ablation, using an enhanced sonication technique—a pig’s muscle model. Eur J Radiol 2006; 59:190–7PubMedCrossRef

67.

Inbar Y, Hanannel A, Freunlich D, et al. Controlled apnea for focused ultrasound ablation of liver tissue—animal model. In: Proceedings of the Twelfth Meeting of the International Society for Magnetic Resonance in Medicine, Kyoto, Japan. Berkeley, CA: ISMRM, 2004:2697

68.

Kopelman D, Inbar Y, Hanannel A, et al. Magnetic resonance guided focused ultrasound surgery (MRgFUS). Ablation of liver tissue—a porcine model. Eur J Radiol 2006; 59:157–62PubMedCrossRef

69.

Kopelman D, Inbar Y, Hanannel A, et al. Magnetic resonance guided focused ultrasound surgery (MRgFUS). Four ablation treatments of a single canine hepatocellular adenoma. HPB Surg 2006; 8:292–8

70.

Hynynen K, Vykhodtseva NI, Chung AH, Sorrentino V, Colucci V, Jolesz FA. Thermal effects of focused ultrasound on the brain: determination with MR. Radiology 1997; 204:247–53PubMed

71.

Vykhodtseva N, McDannold N, Martin H, Bronson RT, Hynynen K. Apoptosis in ultrasound-produced threshold lesions in the rabbit brain. Ultrasound Med Biol 2001; 27:111–7PubMedCrossRef

72.

Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 2001; 220:640–6PubMedCrossRef

73.

Clement GT, White PJ, King RL, McDannold N, Hynynen K. A magnetic resonance imaging-compatible, large-scale array for trans-skull ultrasound surgery and therapy. J Ultrasound Med 2005; 24:1117–25PubMed

74.

Kopelman D, Inbar Y, Hanannel A, et al. Magnetic resonance guided focused ultrasound (MRgFUS) ablation of soft tissue at bone-muscle interface: a porcine model. Eur J Clin Invest (in press)

75.

Hynynen K, Pomeroy O, Smith DN, et al. MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology 2001; 219:176–85PubMed

76.

Gianfelice D, Khiat A, Amara M, Belblidia A, Boulanger Y. MR imaging-guided focused US ablation of breast cancer: histopathologic assessment of effectiveness—initial experience. Radiology 2003; 227:849–55PubMedCrossRef

77.

Gianfelice D, Khiat A, Boulanger Y, Amara M, Belblidia A. Feasibility of magnetic resonance imaging–guided focused ultrasound surgery as an adjunct to tamoxifen therapy in high-risk surgical patients with breast carcinoma. J Vasc Interv Radiol 2003; 14:1275–82PubMed

78.

Furusawa H, Namba K, Thomsen S et al. Magnetic resonance-guided focused ultrasound surgery of breast cancer: reliability and effectiveness. J Am Coll Surg 2006; 203(1):54-63PubMedCrossRef

79.

Tempany CM, Stewart EA, McDannold N, Quade BJ, Jolesz FA, Hynynen K. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 2003; 226:897–905PubMedCrossRef

80.

Stewart EA, Gedroyc WMW, Tempany CMC, et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol 2003; 189:48–54PubMedCrossRef

81.

McDannold N, Tempany CM, Fennessy FM et al. Uterine leiomyomas: MR imaging-based thermometry and thermal dosimetry during focused ultrasound thermal ablation. Radiology 2006; 240(1):263–72PubMedCrossRef

82.

Stewart EA, Rabinovici J, Tempany CM et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 2006; 85:22–9PubMedCrossRef

83.

Heslev GK, Felmlee JP, Gebhart JB, et al. Noninvasive treatment of uterine fibroids: early Mayo Clinic experience with magnetic resonance imaging-guided focused ultrasound. Mayo Clin Proc 2006; 81(7):936–42CrossRef

84.

Smart OC, Hindley JT, Regan L, Gedroyc WM. Magnetic resonance guided focused ultrasound surgery of uterine fibroids—the tissue effects of GnRH agonist pretreatment. Eur J Radio 2006; 59(2):163-7CrossRef

85.

Jolesz FA, Hynynen K, McDannold N, Freundlich D, Kopelman D. Noninvasive thermal ablation of hepatocellular carcinoma by using magnetic resonance imaging-guided focused ultrasound. Gastroenterology 2004; 127:S242–7PubMedCrossRef

86.

Catane R, Beck A, Inbar Y, et al. MR guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases—preliminary clinical experience. Ann Oncol (in press). http://annonc.oxfordjournals.org/cgi/content/abstract/annonc;mdl335V1

87.

Ram Z, Cohen ZR, Har Nof S, et al. Magnetic resonance imaging-guided high-intensity focused ultrasound for brain tumor therapy. Neurosurgery 2006, 59(5):949–56PubMed

88.

Hynynen K, Jolesz FA. Principles of MR-guided focused ultrasound. In: Lufkin RB, ed. Interventional MRI. St. Louis: Mosby, 1999; 237–243

Titel: Magnetic Resonance–Guided Focused Ultrasound Surgery for the Noninvasive Curative Ablation of Tumors and Palliative Treatments: A Review
verfasst von: Doron Kopelman, MD
Moshe Papa, MD
Publikationsdatum: 01.05.2007
Verlag: Springer-Verlag
Erschienen in: Annals of Surgical Oncology / Ausgabe 5/2007
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-006-9326-z

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2007

Eighteen Sensations After Breast Cancer Surgery: A 5-Year Comparison of Sentinel Lymph Node Biopsy and Axillary Lymph Node Dissection

Clinicopathological Roles of Alterations of Tumor Suppressor Gene p16 in Papillary Thyroid Carcinoma

Review of Distribution of Nodal Disease in Differentiated Thyroid Cancers in an Oncosurgical Center in Sri Lanka

Breast Cancer Sentinel Lymph Node Identification Rates: The Influence of Radiocolloid Mapping, Case Volume, and the Place of the Procedure

Carcinoid of the Rectum Risk Stratification (CaRRs): A Strategy for Preoperative Outcome Assessment

Loss of MAL Expression in Precancerous Lesions of the Esophagus

Update Chirurgie